p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
Aprea Therapeutics
Aprea Therapeutics
Henry Ford Health System
City of Hope Medical Center
pharmaand GmbH
Big Ten Cancer Research Consortium
NYU Langone Health
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline